Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
New Directions for Mental Health Services
|
October 14, 2000
Diagnosis and treatment of HIV-associated neurocognitive disorders
S J Ferrando
Psychosomatics
|
January 1, 1991
Adverse neuropsychiatric effects of dopamine antagonist medications. Misdiagnosis in the medical setting
S J Ferrando, S J Eisendrath
Journal of Psychoactive Drugs
|
April 1, 1991
HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management
S J Ferrando, S L Batki
New Directions for Mental Health Services
|
October 14, 2000
Substance abuse and HIV infection
S J Ferrando, S L Batki
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 8, 2000
Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year
S J Ferrando, J G Rabkin, L Poretsky
General Hospital Psychiatry
|
March 1, 1997
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms
S J Ferrando, J D Goldman, W E Charness
Journal of Psychosomatic Research
|
October 29, 2000
Psychological and physical health correlates of body cell mass depletion among HIV+ men
G J Wagner, S J Ferrando, J G Rabkin
Journal of Psychosomatic Research
|
November 9, 2000
Health locus of control, distress, and utilization of protease inhibitors among HIV-positive men
S Evans, S J Ferrando, J G Rabkin, et al.
Comprehensive Psychiatry
|
May 1, 1997
Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study
J G Rabkin, S J Ferrando, L B Jacobsberg, et al.
Psychoneuroendocrinology
|
January 14, 2000
DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters
J G Rabkin, S J Ferrando, G J Wagner, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
New Directions for Mental Health Services
|
October 14, 2000
Diagnosis and treatment of HIV-associated neurocognitive disorders
S J Ferrando
Psychosomatics
|
January 1, 1991
Adverse neuropsychiatric effects of dopamine antagonist medications. Misdiagnosis in the medical setting
S J Ferrando, S J Eisendrath
Journal of Psychoactive Drugs
|
April 1, 1991
HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management
S J Ferrando, S L Batki
New Directions for Mental Health Services
|
October 14, 2000
Substance abuse and HIV infection
S J Ferrando, S L Batki
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 8, 2000
Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year
S J Ferrando, J G Rabkin, L Poretsky
General Hospital Psychiatry
|
March 1, 1997
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms
S J Ferrando, J D Goldman, W E Charness
Journal of Psychosomatic Research
|
October 29, 2000
Psychological and physical health correlates of body cell mass depletion among HIV+ men
G J Wagner, S J Ferrando, J G Rabkin
Journal of Psychosomatic Research
|
November 9, 2000
Health locus of control, distress, and utilization of protease inhibitors among HIV-positive men
S Evans, S J Ferrando, J G Rabkin, et al.
Comprehensive Psychiatry
|
May 1, 1997
Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study
J G Rabkin, S J Ferrando, L B Jacobsberg, et al.
Psychoneuroendocrinology
|
January 14, 2000
DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters
J G Rabkin, S J Ferrando, G J Wagner, et al.
Page
of 2